new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Basilea Pharmaceutica Ag patents

Recent patent applications related to Basilea Pharmaceutica Ag. Basilea Pharmaceutica Ag is listed as an Agent/Assignee. Note: Basilea Pharmaceutica Ag may have other listings under different names/spellings. We're not affiliated with Basilea Pharmaceutica Ag, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Basilea Pharmaceutica Ag-related inventors




Date Basilea Pharmaceutica Ag patents (updated weekly) - BOOKMARK this page
05/04/17Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
11/03/16Use of bubr1 as a biomarker of drug response to furazanobenzimidazoles
05/05/16Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
12/03/15Selected macrolides with pde4-inhibiting activity
08/06/15Oxidation process for preparing 3-formyl-cephem derivatives
06/11/15Combination therapy for the treatment of cancer and immunosuppression
03/19/15Novel bicyclic antibiotics
03/12/15Tricyclic antibiotics
01/29/15Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
01/01/15Crystalline (6r,7r)-7--3- [(r)-1'-tert-butoxycarbonyl-2-oxo-[1,3']bipyrrolidinyl-(3e)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0] oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use
08/07/14Novel bicyclic antibiotics
05/22/14New macrolides and their use
01/23/14Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
12/26/13Use of stathmin as a biomarker of drug response to furazanobenzimidazoles
10/17/13Process for the manufacture of bridged monobactam intermediates
11/01/12New macrolides and their use
10/18/12Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
09/27/12Tricyclic antibiotics
02/16/12Novel bicyclic antibiotics
06/09/11Crystalline (6r,7r)-7--3- [(r)-1'-tert-butoxycarbonyl-2-oxo-[1,3']bipyrrolidinyl-(3e)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0] oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use
12/02/10Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)-carbamoyl-7-oxo-2,6-diaza-bicyclo [3.2.0.]heptane-6-sulfonic acid derivatives
06/10/10Combination medicaments for treating bacterial infections







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Basilea Pharmaceutica Ag in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Basilea Pharmaceutica Ag with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';